Anti-IL-5 (Reslizumab), Humanized Antibody

Anti-IL-5 (Reslizumab), Humanized Antibodyis available at Gentaur for Next week Delivery.

Description: The research-grade biosimilar is a humanized IgG4 kappa monoclonal antibody that targets IL-5. IL-5 is a proinflammatory cytokine that mediates recruitment, activation, growth, differentiation, and survival of eosinophils. Increased production of eosinophils is associated with allergic and non-allergic forms of asthma. The antibody specifically binds to the ERRR region (between amino acids 89-92) of the IL-5, which is necessary for the interaction with the IL-5 receptor located on the eosinophil cell surface. This results in inhibition of IL-5 mediated signaling, prevents maturation of the eosinophils, and eosinophil-mediated inflammation. The original drug received approval from the FDA as an add-on treatment for patients suffering from severe asthma with an eosinophilic phenotype.

Immunogen Sequence:Human IL-5

Target Alternative Name:CEP-38072, DCP 835, DCP-835, SCH-55700, SCH55700, EDF, TRF, IL5

Species Reactivities:Human

Tag Line:The biosimilar antibody is a humanized monoclonal antibody that targets IL-5, disrupts IL-5 mediated signaling, and thus reduces the production and survival of eosinophils, and eosinophil-mediated inflammation.

Formulation:In PBS, pH 7.5

Purification: Protein A purified

Application:/

Positive Control:/

Application And Usages:/

Handling:The antibody solution should be gently mixed before use.